Androgen-deprivation therapy for prostate cancer may increase the risk of cardiac death among men who have congestive heart failure or who have experienced a previous myocardial infarction, a...
NATIONAL HARBOR, MD. – Relizen, a nonhormonal purified pollen extract with demonstrated efficacy in treating vasomotor symptoms of menopause, had negligible effects on the CYP2D6 enzyme at five times...
Counseling adults about their individual risk of colorectal cancer generally did not convince them to seek screening for the disease, according to a randomized controlled trial reported online...
The Food and Drug Administration has approved new labeling for the opioid analgesic Embeda to include information about the drug’s abuse-preventive properties, the agency announced Oct. 17.
The...
Remarks given during a session of the ASCO Breast Cancer Symposium titled Ductal Carcinoma in Situ Debate: Treatment vs. Observation
Dr. Kuerer comments: There has been a marked...
With the increasing use of ultrasound in the first trimester, asymptomatic adnexal masses are being diagnosed earlier in pregnancy, leaving providers with an often difficult clinical scenario. The...
Women who have inflammatory bowel disease, particularly those with Crohn’s disease, are at increased risk for developing cervical neoplasia, according to a report published online in Clinical...
Adding abiraterone to standard neoadjuvant therapy using luteinizing hormone-releasing hormone agonists induces markedly more effective androgen suppression within the prostate tissue in men who have...
Adjuvant radiotherapy continues to protect against recurrences – albeit “modestly” – for a full 20 years after women undergo breast-conserving surgery for DCIS, according to a report published...
Using a 70-gene signature screening tool for adjuvant chemotherapy decisions cost significantly more than did other methods, including giving chemotherapy to all patients, but did not confer any...
